Navigation Links
HIV treatment use increases in the US
Date:9/3/2012

Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious and have healthier immune systems at death, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The study was nested in the NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design), which is the largest cohort of HIV-infected adults in North America. The findings are published in the September 4 edition of Annals of Internal Medicine.

The study included more than 45,000 HIV-infected participants receiving clinical care for HIV. The study population was demographically similar to the U.S. population living with HIV, according to national surveillance data from the Centers for Disease Control and Prevention. Over the study period, the researchers found that the proportion of HIV-infected participants prescribed HAART increased 9 percentage points to 83 percent. During this time, the researchers also observed an increase in viral load suppression among those with HIV, regardless of treatment. Suppression of viral load reduces the likelihood of transmitting HIV to others. Among those taking HAART, the proportion with a suppressed viral load increased from 54 percent to 81 percent.

"This is good news for the HIV epidemic in the U.S., but there is room for improvement," said Keri N. Althoff, PhD, MPH, lead author of the study and assistant professor in the Bloomberg School's Department of Epidemiology. "We need to continue to focus on linking HIV-infected adults into care and effective treatment, not only for the individual's health, but to reduce the likelihood of transmission to others."

The analysis also found an increase in median CD4 count for participants who died from HIV during the study period. Median counts increased at the time of death
'/>"/>

Contact: Tim Parsons
tmparson@jhsph.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Lyme retreatment guidance may be flawed
2. WSU/USDA scientist creates test, treatment for malaria-like sickness in horses
3. RI Hospital: Use of PMP may increase demand for drug treatment, reduce painkiller abuse
4. Gene discovery could improve treatment for acute myeloid leukemia
5. Should high-dose interleukin-2 continue to be the treatment of choice for metastatic melanoma?
6. Powerful class of antioxidants may be potent Parkinsons treatment
7. ECGs administered by paramedics can speed treatment for severe heart attacks
8. Reorganizing brain could lead to new stroke, tinnitus treatments
9. OHSU discovery may lead to new treatment for ALS
10. Real-life spider men using protein found in venom to develop muscular dystrophy treatment
11. Transforming cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... In Brazil , cloud computing is fast ... and 42 percent planning to invest in them by the ... the companies will be investing in these solutions for the ... the region are currently opting for the private cloud model, ... attention in the coming years. This trend is in line ...
(Date:3/2/2015)... JOSE, Calif. , March 2, 2015 /PRNewswire/ ... the leading developer of human interface solutions, today ... technology that is designed to enable rapid and ... Natural ID™ module for gaming is a turnkey ... ODMs the ability to quickly integrate fingerprint ID ...
(Date:2/25/2015)... Feb. 25, 2015  ABC Financial Services (ABC), ... the Health and Fitness Industry, today announced enhancements ... MYiCLUBonline.  The latest upgrade includes advances to the ... cardless check-in via Identity One fingerprint biometrics. The ... through interactive displays at the International Health, Racquet ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3
... that slows the aging process. The biologists, ... increases the activity of mitochondria, the tiny power generators in ... live and die. "We took this gene ... the fly and asked whether this impacts the aging process," ...
... Mass., Nov. 9, 2011 The Children,s Hospital ... institute, today announced they have formed a partnership, ... bioinformatics analysis at a newly established, state-of-the-art Joint ... focus on the discovery of genes underpinning rare ...
... Almond, Joseph J. Doyle, Jr., Amanda E. Kowalski and ... Award for their paper entitled "Estimating Marginal Returns to ... The authors applied a cutting-edge econometric methodology to evaluate ... They found compelling evidence that such care enables very ...
Cached Biology News:UCLA biologists slow the aging process in fruit flies 2UCLA biologists slow the aging process in fruit flies 3The Children's Hospital of Philadelphia and BGI Announce Partnership and New Joint Genome Center to Target Pediatric Diseases 2The Children's Hospital of Philadelphia and BGI Announce Partnership and New Joint Genome Center to Target Pediatric Diseases 3
(Date:3/25/2015)... and the HAGUE, Netherlands ... two-year results of LES Stimulation therapy for chronic gastro-esophageal ... journal Surgery [ Surgery . 2015; ... of its minimally-invasive therapy. The study ... duration of 11 years and taking prescribed daily proton ...
(Date:3/25/2015)... , March 25, 2015  18 piglets born ... intense research by scientists in the College of Agriculture ... represent a breakthrough in the field of genetic ... the Department of Animal & Avian Sciences (ANSC) and ... ANSC, successfully produced genome-edited pigs using a recently ...
(Date:3/25/2015)... 25, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , announces ... its target therapy drug candidate ENMD-2076 in triple-negative breast ... of Medical Sciences in Beijing , ...
(Date:3/25/2015)... March 25, 2015 The ... on the basis of products, technology, platform, ... this report are radar, laser, infra-red, microwave, ... video guidance systems, terrain mapping systems, and ... data Tables and 60 Figures spread through ...
Breaking Biology Technology:EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3University of Maryland Researchers Successfully Produce Genome-edited Pigs Using Revolutionary Technology 2CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 2CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 3CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 4CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 5Smart Weapons Market is Estimate to reach $6.1 Billion by 2020 Worth $6.1 Billion by 2020 - New Report by MarketsandMarkets 2Smart Weapons Market is Estimate to reach $6.1 Billion by 2020 Worth $6.1 Billion by 2020 - New Report by MarketsandMarkets 3
... in ... platelets, WORCESTER, Mass., Sept. ... bacterial contaminants in,blood cells and tissue, has received 510 (k) clearance for ... This provides,Verax authorization to market the device, which cuts the detection time ...
... 19 Protalix,BioTherapeutics, Inc. (Amex: PLX ), ... Chief Executive Officer, will present at the UBS ... York on Monday, September,24, 2007, at 9:30 a.m. ... live via webcast at, http://events.streamx.us/us/event/eventdetails.aspx?id=ubs20070924 .,Following the live ...
... Md., Sept. 19 Stem cell company,Neuralstem, Inc. ... has received notice,that the United States Patent and ... the reexamination of the four StemCells, Inc. (Nasdaq:,STEM) ... ) "The Patent Office has rejected ...
Cached Biology Technology:Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test 2Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test 3Protalix BioTherapeutics to Present at UBS Global Life Sciences Conference 2Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc. 2Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc. 3
Trypsin (Pig Pancreas) (TPCK Treated, Highly Purified)...
Homo sapiens palladin...
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: